08222017Headline:

Philadelphia, Pennsylvania

HomePennsylvaniaPhiladelphia

Email Jamie Sheller
Jamie Sheller
Jamie Sheller
Attorney • (800) 883-2299

About Nephrogenic Fibrosing Dermopathy

Comments Off

Nephrogenic Fibrosing Dermopathy (NFD), also known as Nephrogenic Systemic Fibrosis (NSF), is a skin disease that was first identified in 1997. NFD/NSF has been identifed in people with impaired renal function or kidney disease. Some characteristics of nephrogenic fibrosing dermopathy or nephrogenic system fibrosis include tight, rigid skin that may make it difficult to bend the joints. The disease may also include fibrosis leading to multiorgan failure and death. Though there is no known treatment for NFD/NSF, improved kidney function may slow the development of the disease. Recently, nephrogenic fibrosing dermopathy/nephrogenic system fibrosis has been linked to gadolinium-based contrast agents used in imaging studies, like MRI’s. It is recommended that patients with moderate to end-stage renal disease should have prompt dialysis after getting an imaging study with a gadolinium-based contrast agent.